553 filings
Page 12 of 28
CORRESP
LRMR
Larimar Therapeutics Inc
27 Apr 20
Correspondence with SEC
12:00am
8-K
LRMR
Larimar Therapeutics Inc
24 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
UPLOAD
LRMR
Larimar Therapeutics Inc
24 Apr 20
Letter from SEC
12:00am
PRER14A
LRMR
Larimar Therapeutics Inc
10 Apr 20
Preliminary revised proxy
4:38pm
CORRESP
LRMR
Larimar Therapeutics Inc
10 Apr 20
Correspondence with SEC
12:00am
UPLOAD
LRMR
Larimar Therapeutics Inc
6 Apr 20
Letter from SEC
12:00am
DEFA14A
LRMR
Larimar Therapeutics Inc
9 Mar 20
Additional proxy soliciting materials
12:00am
8-K
LRMR
Larimar Therapeutics Inc
9 Mar 20
Entry into a Material Definitive Agreement
12:00am
PREM14A
LRMR
Larimar Therapeutics Inc
6 Mar 20
Preliminary proxy related to merger
5:32pm
S-8
LRMR
Larimar Therapeutics Inc
5 Mar 20
Registration of securities for employees
4:42pm
10-K
2019 FY
LRMR
Larimar Therapeutics Inc
Annual report
5 Mar 20
4:31pm
8-K
LRMR
Larimar Therapeutics Inc
5 Mar 20
Zafgen Reports Fourth Quarter and Full Year 2019 Financial Results
4:16pm
SC 13G
Sio Capital Management, LLC
14 Feb 20
Zafgen, Inc.
4:00pm
SC 13G/A
EcoR1 Capital, LLC
14 Feb 20
Zafgen, Inc.
1:58pm
SC 13G/A
Armistice Capital, LLC
14 Feb 20
Zafgen, Inc.
11:30am
SC 13G/A
LRMR
Larimar Therapeutics Inc
14 Feb 20
Zafgen, Inc.
12:00am
SC 13G/A
LRMR
Larimar Therapeutics Inc
13 Feb 20
Beneficial ownership report (amended)
10:04am
SC 13G
LRMR
Larimar Therapeutics Inc
12 Feb 20
Beneficial ownership report
11:51am
SC 13G
Sphera Funds Management LTD.
11 Feb 20
Zafgen, Inc.
12:19pm
DEFA14A
LRMR
Larimar Therapeutics Inc
5 Feb 20
Additional proxy soliciting materials
4:31pm